139 related articles for article (PubMed ID: 32982436)
1. Evaluation of Alterations to Bile Ducts and Laboratory Values During the First 3 Months After Irreversible Electroporation of Malignant Hepatic Tumors.
Bäumler W; Sebald M; Einspieler I; Schicho A; Schaible J; Wiggermann P; Dollinger M; Stroszczynski C; Beyer LP
Cancer Manag Res; 2020; 12():8425-8433. PubMed ID: 32982436
[TBL] [Abstract][Full Text] [Related]
2. Bile Duct Injury after Irreversible Electroporation of Hepatic Malignancies: Evaluation of MR Imaging Findings and Laboratory Values.
Dollinger M; Zeman F; Niessen C; Lang SA; Beyer LP; Müller M; Stroszczynski C; Wiggermann P
J Vasc Interv Radiol; 2016 Jan; 27(1):96-103. PubMed ID: 26777402
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous ablation of peribiliary tumors with irreversible electroporation.
Silk MT; Wimmer T; Lee KS; Srimathveeravalli G; Brown KT; Kingham PT; Fong Y; Durack JC; Sofocleous CT; Solomon SB
J Vasc Interv Radiol; 2014 Jan; 25(1):112-8. PubMed ID: 24262034
[TBL] [Abstract][Full Text] [Related]
4. Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up.
Dollinger M; Müller-Wille R; Zeman F; Haimerl M; Niessen C; Beyer LP; Lang SA; Teufel A; Stroszczynski C; Wiggermann P
PLoS One; 2015; 10(8):e0135773. PubMed ID: 26270651
[TBL] [Abstract][Full Text] [Related]
5. Midterm Safety and Efficacy of Irreversible Electroporation of Malignant Liver Tumors Located Close to Major Portal or Hepatic Veins.
Distelmaier M; Barabasch A; Heil P; Kraemer NA; Isfort P; Keil S; Kuhl CK; Bruners P
Radiology; 2017 Dec; 285(3):1023-1031. PubMed ID: 28799842
[TBL] [Abstract][Full Text] [Related]
6. Biliary complications and efficacy after ablation of peribiliary tumors using irreversible electroporation (IRE) or radiofrequency ablation (RFA).
Thamtorawat S; Patanawanitkul R; Rojwatcharapibarn S; Chaiyasoot W; Tongdee T; Yodying J; Sorotpinya S
Int J Hyperthermia; 2022; 39(1):751-757. PubMed ID: 35649727
[TBL] [Abstract][Full Text] [Related]
7. Changes in gadoxetic-acid-enhanced MR imaging during the first year after irreversible electroporation of malignant hepatic tumors.
Bäumler W; Schicho A; Schaible J; Verloh N; Senk K; Wiggermann P; Stroszczynski C; Beyer LP
PLoS One; 2020; 15(11):e0242093. PubMed ID: 33201902
[TBL] [Abstract][Full Text] [Related]
8. Acute and subacute effects of irreversible electroporation on normal common bile ducts in a rabbit model.
Li Q; Ren F; Zhang Y; Chang P; Wang Y; Ma T; Hu L; Wu R; Wang B; Lv Y
J Hepatobiliary Pancreat Sci; 2020 Oct; 27(10):776-784. PubMed ID: 32696618
[TBL] [Abstract][Full Text] [Related]
9. Incidence and evolution of venous thrombosis during the first 3 months after irreversible electroporation of malignant hepatic tumours.
Bäumler W; Sebald M; Einspieler I; Wiggermann P; Schicho A; Schaible J; Lürken L; Dollinger M; Stroszczynski C; Beyer LP
Sci Rep; 2019 Dec; 9(1):19876. PubMed ID: 31882716
[TBL] [Abstract][Full Text] [Related]
10. Assessment of chronological effects of irreversible electroporation on hilar bile ducts in a porcine model.
Choi JW; Lu DS; Osuagwu F; Raman S; Lassman C
Cardiovasc Intervent Radiol; 2014 Feb; 37(1):224-30. PubMed ID: 24196262
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Hepatic Lesions After non-Thermal Tumor Ablation by Irreversible Electroporation in a Pig Model.
Jeon SM; Davaa E; Jiang Y; Jenjob R; Truong NT; Shin KJ; Jeong S; Yang SG
Technol Cancer Res Treat; 2023; 22():15330338221147122. PubMed ID: 37861099
[TBL] [Abstract][Full Text] [Related]
12. Novel Ablation Therapy Using Endoscopic Irreversible Electroporation in the Bile Duct: A Pilot Animal Study.
Lee KW; Lee JM; Choi HS; Kim ES; Keum B; Seo YS; Jeen YT; Um SH; Lee HS; Chun HJ; Kim CD; Oh CH; Kim HB
Clin Endosc; 2021 May; 54(3):413-419. PubMed ID: 33076633
[TBL] [Abstract][Full Text] [Related]
13. Irreversible electroporation for liver cancer ablation: A meta analysis.
Yu M; Li S
Eur J Surg Oncol; 2022 Jun; 48(6):1321-1330. PubMed ID: 35012834
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous Irreversible Electroporation (IRE) of Hepatic Malignancy: A Bi-institutional Analysis of Safety and Outcomes.
Mafeld S; Wong JJ; Kibriya N; Stenberg B; Manas D; Bassett P; Aslam T; Evans J; Littler P
Cardiovasc Intervent Radiol; 2019 Apr; 42(4):577-583. PubMed ID: 30465255
[TBL] [Abstract][Full Text] [Related]
15. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
[TBL] [Abstract][Full Text] [Related]
16. Irreversible Electroporation to Treat Unresectable Colorectal Liver Metastases (COLDFIRE-2): A Phase II, Two-Center, Single-Arm Clinical Trial.
Meijerink MR; Ruarus AH; Vroomen LGPH; Puijk RS; Geboers B; Nieuwenhuizen S; van den Bemd BAT; Nielsen K; de Vries JJJ; van Lienden KP; Lissenberg-Witte BI; van den Tol MP; Scheffer HJ
Radiology; 2021 May; 299(2):470-480. PubMed ID: 33724066
[TBL] [Abstract][Full Text] [Related]
17. Irreversible electroporation of the liver and liver hilum in swine.
Charpentier KP; Wolf F; Noble L; Winn B; Resnick M; Dupuy DE
HPB (Oxford); 2011 Mar; 13(3):168-73. PubMed ID: 21309933
[TBL] [Abstract][Full Text] [Related]
18. Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results.
Frühling P; Nilsson A; Duraj F; Haglund U; Norén A
Eur J Surg Oncol; 2017 Apr; 43(4):751-757. PubMed ID: 28109674
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound-guided percutaneous irreversible electroporation of hepatic and abdominal tumors not eligible for surgery or thermal ablation: a western report on safety and efficacy.
Giorgio A; Amendola F; Calvanese A; Ingenito E; Santoro B; Gatti P; Ciracì E; Matteucci P; Giorgio V
J Ultrasound; 2019 Mar; 22(1):53-58. PubMed ID: 30843171
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous Irreversible Electroporation of Unresectable Hilar Cholangiocarcinoma (Klatskin Tumor): A Case Report.
Melenhorst MC; Scheffer HJ; Vroomen LG; Kazemier G; van den Tol MP; Meijerink MR
Cardiovasc Intervent Radiol; 2016 Jan; 39(1):117-21. PubMed ID: 25994516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
